Skip secondary menu

NINDS Parkinson’s Disease Biomarkers Program. Scientific Liaison Group Meeting


Meeting

Agenda

Executive Summary  

 

PARTICIPANT LIST

Laurie Arrants
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Debra Babcock, M.D., Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Laurel Beckett, Ph.D.
UC Davis
Working Group: Discovery/Exploratory Science

Ken J. Bergmann, M.D., FAAN
U.S. Food and Drug Administration
Working Group: Clinical

David Brooks, M.D., D.Sc.
Imperial College
Working Group: Clinical

Andrea Brucin, Ph.D.
Foundation for the National Institutes of Health

Lucie Bruijn, Ph.D.
ALS Association

Neil Buckholtz, Ph.D.
National Institute on Aging
National Institutes of Health
Working Group: Clinical

Cindy Casaceli
University of Rochester

Jesse Cedarbaum, M.D.
Cytokinetics, Inc.

Christopher Coffey, Ph.D.
University of Iowa

Thomas Comery
Pfizer, Inc.
Working Group: Clinical

Amy Comstock Rick, J.D.
Parkinson's Action Network (PAN)
Working Group: Clinical

Roderick A. Corriveau, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Merit Cudkowicz, M.D.
Harvard

Alison Drone
Foundation for the National Institutes of Health

Karen L. Edwards, Ph.D.
University of Washington

Marian Emr
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Greg Farber, Ph.D.
National Institute of Mental Health
National Institutes of Health

Mats Ferm
Astra Zeneca
Working Group: Discovery/Exploratory Science

Bob Finkelstein, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Wendy Galpern, M.D., Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Katrina Gwinn, M.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Mark Hallett, M.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Working Group: Clinical

Franz Hefti, Ph.D.
Acumen Pharmaceuticals, Inc.
Working Group: Discovery/Exploratory Science

Lynn D. Hudson, Ph.D.
Critical Path Institute

Andreas Jeromin, Ph.D.
Banyan Biomarkers, Inc.
Working Group: Clinical

Walter Koroshetz, M.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Rainer Kuhn, Ph.D.
Novartis
Working Group: Discovery/Exploratory Science

Story Landis, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Chi-Ming Lee, Ph.D.
Astra Zeneca

Ernie Lyons, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Robert Martone
Covance Biomarker Center of Excellence
Working Group: Discovery/Exploratory Science (Chair)

Darius Matusevicius, M.D., Ph.D.
Astra Zeneca
Working Group: Clinical

Matthew McAuliffe, Ph.D.
Center for Information Technology
National Institutes of Health

Elizabeth McNeil, M.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Jane Paulsen, Ph.D.
University of Iowa
Working Group: Clinical

Joel Perlmutter, M.D.
Washington University in St. Louis
Working Group: Discovery/Exploratory Science

Ron Petersen, M.D., Ph.D.
Mayo Clinic College of Medicine

Shanta Rajaram, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Bernard Ravina, M.D., M.S.
Biogen
Working Group: Clinical

Ian Reynolds, Ph.D.

Henry Rodriguez, Ph.D., M.B.A.
National Cancer Institute
National Institutes of Health
Working Group: Clinical

Gary Romano, M.D., Ph.D.
Janssen Pharmaceuticals
Working Group: Clinical

Yaffa Rubinstein, Ph.D.
National Center for Advancing Translational Sciences
National Institutes of Health

Kathleen Shannon, M.D.
Rush University Medical Center
Working Group: Discovery/Exploratory Science

Todd Sherer, Ph.D.
Michael J. Fox Foundation for Parkinson's Research
Working Group: Discovery/Exploratory Science

Beth-Anne Sieber, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

John Sims, M.D.
Eli Lilly
Working Group: Clinical

Holly Soares
Bristol Myers Squibb
Working Group: Clinical

Coryse St. Hillaire-Clarke, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

David Standaert, M.D., Ph.D.
University of Alabama at Birmingham
Working Group: Clinical (Chair)

Margaret Sutherland, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Anna Taylor, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Barbara Tilley, Ph.D.
University of Texas
Working Group: Clinical

Christine L. Torborg, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Dave Weiner, M.D.
Working Group: Discovery/Exploratory Science

Alan L. Willard, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health

Janet Woodcock, M.D.
U.S. Food and Drug Administration
Working Group: Clinical

Last updated December 23, 2013